Long Valley, NJ, United States of America

Patricia Pelton




Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Celebrating the Innovations of Patricia Pelton: A Pioneer in Pharmaceutical Inventions**

Introduction

Patricia Pelton, an accomplished inventor based in Long Valley, NJ, has significantly contributed to the field of pharmaceutical innovations. With a remarkable portfolio of 10 patents, Pelton's work is primarily focused on compounds that impact lipid metabolism and related health conditions. Her inventions highlight her dedication to advancing medical treatments that address various metabolic disorders.

Latest Patents

Patricia Pelton's latest patents showcase her ingenuity in developing novel compounds. One of her notable inventions is the formulation of benzoazepin-oxy-acetic acid derivatives, which serve as PPAR-delta agonists aimed at increasing HDL-C, lowering LDL-C, and reducing cholesterol levels. This invention provides a new avenue for treating numerous conditions, including diabetes, nephropathy, cardiovascular diseases, and related disorders associated with lipid metabolism and energy homeostasis.

Another significant contribution is her work on 4-((phenoxyalkyl)thio)-phenoxyacetic acids and their analogs. This invention emphasizes their use as PPAR modulators for treating or inhibiting the progression of dyslipidemia, showcasing Pelton's focus on addressing complex health issues through innovative compounds.

Career Highlights

Patricia Pelton currently holds a key position at Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson renowned for its pharmaceutical advancements. Throughout her career, she has consistently been at the forefront of research and development, contributing to groundbreaking solutions in the pharmaceutical arena.

Collaborations

In her journey of innovation, Pelton has collaborated with esteemed colleagues in her field, including Gee-Hong Kuo and Keith T. Demarest. Their combined expertise has facilitated the successful development of her patented compounds, enhancing the potential impact of her work on metabolic disorders.

Conclusion

Patricia Pelton's innovations continue to influence the pharmaceutical industry, particularly in the treatment of lipid metabolism disorders. Her dedication to research and development, coupled with her collaborative spirit, underscores her role as a leading inventor in the field. As she continues to build on her portfolio of patents, the medical community eagerly anticipates the positive changes her innovations will bring to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…